Lupin Ltd.
SET SMS ALERT
| 5-Day | 206,640 |
| 10-Day | 161,923 |
| 30-Day | 209,584 |
| 5-Day | 206,640 |
| 10-Day | 161,923 |
| 30-Day | 209,584 |
Depth
Market Depth (23 Oct 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 25 | 870.00 | 890.00 | 550 |
| 1 | 861.10 | 895.00 | 200 |
| 40 | 860.00 | 896.00 | 10 |
| 23 | 850.00 | 899.00 | 15 |
| 2 | 848.00 | 900.00 | 440 |
| 1578 | Total | 4025 | Total |
Buy Qty
1578
Sell QTY
4025
| 5-Day | 2,256,046 |
| 10-Day | 2,144,589 |
| 30-Day | 3,230,279 |
| 5-Day | 2,256,046 |
| 10-Day | 2,144,589 |
| 30-Day | 3,230,279 |
- Quote
- CHARTS
- NEWS
- COMMENTS44 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Lupin
Sentimeter
100% of moneycontrol users recommend buying Lupin.
What's your call on Lupin today?
Read 44 investor views
Top Trading Ideas
19 October 2018
sell HCLTech Oct Fut |
Entry Price (Rs) 1,030.00 |
Exit Price (Rs) 1,005.00 |
Gain (Rs) 25.00 |
sell TVSMotor Oct Fut |
Entry Price (Rs) 522.30 |
Exit Price (Rs) 515.80 |
Gain (Rs) 6.00 |
| Days | BSE | NSE |
| 30 | 895.45 | 896.48 |
| 50 | 887.46 | 888.35 |
| 150 | 837.12 | 837.58 |
| 200 | 841.99 | 842.34 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Lupin
| Standalone | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
| Net Sales | 2,512.00 | 2,425.94 | 2,462.11 | 2,528.11 |
| Other Income | 172.53 | 53.23 | 23.98 | 74.33 |
| PBDIT | 501.35 | 454.45 | 498.15 | 541.51 |
| Net Profit | 429.48 | 292.46 | 309.18 | 388.90 |
(In Rs Cr)
| Total Share Capital | 90.42 |
| Net Worth | 15,784.96 |
| Total Debt | 12.29 |
| Net Block | 3,340.66 |
| Investments | 5,362.85 |
| Total Assets | 15,797.25 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 607.05 | 0.00 | 678.80 | 434.80 | 145,651.00 |
| Cipla | 629.20 | 0.00 | 678.00 | 508.10 | 50,664.94 |
| Aurobindo Pharm | 756.80 | 0.00 | 826.35 | 527.05 | 44,341.49 |
| Dr Reddys Labs | 2521.35 | 0.00 | 2687.45 | 1888.00 | 41,865.97 |
| Biocon | 672.15 | 0.00 | 718.35 | 343.50 | 40,329.00 |
| More » | |||||
| Sep' 18 | Jun' 18 | Mar' 18 | Dec' 17 | |
| Promoter | 47.00 | 47.01 | 47.01 | 47.02 |
| Public (FII + DII) | 53.00 | 52.99 | 52.99 | 52.98 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 1,517,771 |
| Reliance Pharma Fund (G) | 1,219,658 |
| SBI Magnum Tax Gain Scheme (G) | 1,211,484 |
| UTI Equity Fund (G) | 995,685 |
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Lupin
Lupin is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 39,888.00 crore.
The company management includes Desh Bandhu Gupta - Chairman, Kamal K Sharma - Vice Chairman, Nilesh Gupta - Managing Director, Manju D Gupta - Executive Director, Ramesh Swaminathan - Executive Director, Vijay Kelkar - Independent Director, R A Shah - Independent Director, Richard Zahn - Independent Director, K U Mada - Independent Director, Dileep C Choksi - Independent Director, Jean-Luc Belingard - Independent Director, Vinita Gupta - Chief Executive Officer.
It is listed on the BSE with a BSE Code of 500257 and the NSE with an NSE Code of LUPIN.
Its Registered office is at Kalpataru Inspire, 3rd Floor,,Off. Western Express Highway, Mumbai,Maharashtra - 400055.
Their Registrars are Link Intime India Pvt. Ltd.
